You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR RELPAX

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for RELPAX

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00259649 ↗	Prospective Survey of Menstrual Migraine & Prevention With Eletriptan	Completed	Pfizer	Phase 4	2004-08-01	Women are followed prospectively for 3 months, recording headaches, other symptoms, and menstrual periods. Those with menstrual migraine are treated perimenstrually with eletriptan for 3 months.
NCT00259649 ↗	Prospective Survey of Menstrual Migraine & Prevention With Eletriptan	Completed	University of Pittsburgh	Phase 4	2004-08-01	Women are followed prospectively for 3 months, recording headaches, other symptoms, and menstrual periods. Those with menstrual migraine are treated perimenstrually with eletriptan for 3 months.
NCT00385008 ↗	TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a Migraine	Completed	GlaxoSmithKline	Phase 3	2006-09-13	An evaluation of tablet disintegration and absorption and gastric transit of sumatriptan and naproxen sodium from a TREXIMA tablet and eletriptan from a RELPAX 40mg tablet.
NCT00871806 ↗	Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water	Completed	Pfizer	Phase 1	2009-04-01	The study will evaluate whether the blood concentrations of eletriptan administered using two test formulations of oral disintegrating tablets are comparable to those observed with the standard commercial tablet.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for RELPAX

Condition Name

Chart
Table

Condition Name for RELPAX
Intervention	Trials
Healthy Volunteers	1
Migraine	1
Migraine Disorders	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for RELPAX
Intervention	Trials
Migraine Disorders	2
Premenstrual Syndrome	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for RELPAX

Trials by Country

Map
Table

Trials by Country for RELPAX
Location	Trials
United States	2
Singapore	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for RELPAX
Location	Trials
Kentucky	1
Pennsylvania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for RELPAX

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for RELPAX
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	1
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for RELPAX
Clinical Trial Phase	Trials
Completed	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for RELPAX

Sponsor Name

Chart
Table

Sponsor Name for RELPAX
Sponsor	Trials
Pfizer	2
University of Pittsburgh	1
GlaxoSmithKline	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for RELPAX
Sponsor	Trials
Industry	4
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.